Head-to-head · Value Score
CoreAge Rx vs Ivim Health
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Ivim Health a 69. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameIvim Health
#249 · Grade C · Watch List
Est. first month
$75/mo on a 6-month plan (compounded); membership billed separately
Save ~94% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 69 — an est. $99/mo first month, with no teaser step-up baked in. Ivim Health isn't out of it: Someone who wants published clinical outcomes and will pin down which $75 is which.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Ivim Health |
|---|---|---|
| Value Score | 93 (A+) | 69 (C) |
| Est. first month | $99/mo | $75/mo on a 6-month plan (compounded); membership billed separately |
| Save vs brand-name | ~89% | ~94% |
| Semaglutide | $99/mo | $75/mo on a 6-month plan (compounded); membership billed separately |
| Tirzepatide | $149/mo | $133/mo on a 6-month plan (compounded); membership billed separately |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Ivim Health
Ivim Health sells compounded semaglutide at $75 and tirzepatide at $133 a month on six-month plans, alongside a separately billed $75 monthly membership, and publishes peer-reviewed outcomes for its program.
Why it's a deal
- Publishes peer-reviewed outcomes in Obesity Pillars rather than citing its own internal success statistics
- Around 100 board-certified clinicians and more than 470,000 patients served, which is among the larger operations tracked here
- $75 a month for semaglutide on the six-month plan is at the very bottom of the range on this site
- Carries the Wegovy Pill, the first FDA-approved oral GLP-1, alongside the compounded products
The fine print
- The medication rates require a six-month plan; the month-to-month figures are higher and are not shown beside them
- A $75 monthly membership is billed separately from the medication, and the site uses the same $75 figure for both, which makes the total easy to misread
- The membership's "first month on us" offer means the second month is when the real total appears
- The states served are not published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Ivim Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.